MEPROBAMATE (Alembic Pharmaceuticals Limited)


Welcome to the PulseAid listing for the MEPROBAMATE drug offered from Alembic Pharmaceuticals Limited. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Alembic Pharmaceuticals Limited
NON-PROPRIETARY NAME: MEPROBAMATE
SUBSTANCE NAME: MEPROBAMATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-07-23
END MARKETING DATE: 0000-00-00


MEPROBAMATE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMEPROBAMATE from Alembic Pharmaceuticals Limited
LABELER NAME: Alembic Pharmaceuticals Limited
DEA SCHEDULE: CIV
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 2013-07-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 46708-019_a0891a32-105b-48bc-a246-5e179d2e7fa1
PRODUCT NDC: 46708-019
APPLICATION NUMBER: ANDA090122

Other MEPROBAMATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alembic Pharmaceuticals Inc.Meprobamate
Alembic Pharmaceuticals LimitedMEPROBAMATE
Avera McKennan HospitalMeprobamate
Dr.Reddy’s Laboratories LimitedMeprobamate
Heritage Pharmaceuticals Inc.Meprobamate
Taro Pharmaceutical Industries Ltd.Meprobamate
Taro Pharmaceuticals U.S.A., Inc.Meprobamate
Watson Laboratories, Inc.Meprobamate